The effect of mirodenafil on the penile erection and corpus cavernosum in the rat model of cavernosal nerve injury
Open Access
- 23 September 2010
- journal article
- Published by Springer Science and Business Media LLC in International Journal of Impotence Research
- Vol. 22 (5), 291-297
- https://doi.org/10.1038/ijir.2010.19
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dose‐dependent pharmacokinetics and first‐pass effects of mirodenafil, a new erectogenic, in ratsBiopharmaceutics & Drug Disposition, 2009
- Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male ratsJournal of Pharmaceutical and Biomedical Analysis, 2009
- Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile DysfunctionThe Journal of Sexual Medicine, 2008
- Penile vascular evaluation and sexual function before and after radical retropubic prostatectomy: 5‐year follow‐upInternational Journal of Andrology, 2008
- Erectile haemodynamic status after radical prostatectomy correlates with erectile functional outcomeBJU International, 2008
- Overcoming Obstacles: Nerve-Sparing Issues in Radical ProstatectomyJournal of Endourology, 2008
- Effects of long‐term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's diseaseBJU International, 2006
- Phosphodiesterase type 5 inhibitors for erectile dysfunctionBJU International, 2005
- Neurophysiology/pharmacology of erectionInternational Journal of Impotence Research, 2001
- RECOVERY OF SPONTANEOUS ERECTILE FUNCTION AFTER NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY WITH AND WITHOUT EARLY INTRACAVERNOUS INJECTIONS OF ALPROSTADILJournal of Urology, 1997